ALEXANDRIA, Virginia, April 30 -- AJAX THERAPEUTICS, INC., New York, New York has been assigned a patent (No. US 11970494 B2, initially filed Nov. 8, 2022) developed by five inventors Craig E. Masse, Cambridge, Massachusetts; Jeremy R. Greenwood, Brooklyn, New York; Jiayi Xu, Marlboro, New Jersey; Sayan Mondal, New York, New York; and Phani Ghanakota, Edison, New Jersey, for "6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors." . . .